Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Heart-kidney Yang deficiency syndrome pattern" refers to a diagnostic pattern in traditional Chinese medicine (TCM), not to a molecular entity such as a receptor, enzyme, transporter, or other canonical therapeutic target. This TCM pattern describes a state of disharmony characterized by insufficient Yang (vital warmth/activity) in both the Heart and Kidney organs, leading to symptoms such as anxiety, insomnia, restlessness, palpitations, irritability, coolness of the lower limbs, fine/rapid pulse, and a red tongue with partial absence of coating[1]. The pattern is often identified through TCM diagnostic criteria rather than Western biomedical markers and is used to underlyingly explain certain syndromes or diseases like hypertension, autonomic dysfunction, and nervous exhaustion[1][9]. TCM practitioners treat this pattern with herbal formulas such as Jiao Tai Wan or Guifudihuang Wan, aiming to tonify (strengthen or warm) the Heart- and Kidney-Yang[2][1]. The concept, therefore, is not a molecule or an actionable drug target but a holistic syndrome framework unique to traditional Chinese medicine. Additional context: - This is not a molecular target and therefore does not have known molecular interactions, classification, or biomarkers in the conventional biomedical sense. - There are no approved drugs targeting the "Heart-kidney Yang deficiency syndrome pattern" as a biomolecular entity. Herbal formulas are used within TCM practice to "correct" or "tonify" this pattern, which may improve symptoms associated with chronic fatigue, autonomic instability, or hypertension through non-specific systemic modulation[2][6]. - No known safety concerns or molecular mechanism of action, as this is not a molecular, cellular, or pharmacological target. Summary: "Heart-kidney Yang deficiency syndrome pattern" is a traditional Chinese medicine pattern diagnosis, but not a receptor, enzyme, or other molecular target. It should not be listed as a therapeutic molecular target in a biomedical drug database.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heart-kidney Yang deficiency syndrome pattern.